Need to improve thromboprophylaxis across the continuum of care for surgical patients

被引:19
作者
Amin, Alpesh N. [1 ]
Lin, Jay [2 ]
Ryan, Amy [3 ]
机构
[1] Univ Calif Irvine, Hospitalist Program, Orange, CA 92868 USA
[2] Sanofi Aventis, Bridgewater, NJ USA
[3] Premier Inc, Charlotte, NC USA
关键词
abdominal surgery; anticoagulation; orthopedic surgery; prophylaxis; venous thromboembolism; DEEP-VENOUS THROMBOSIS; TOTAL HIP; DOUBLE-BLIND; PROLONGED THROMBOPROPHYLAXIS; HOSPITAL DISCHARGE; KNEE-REPLACEMENT; MEDICAL PATIENTS; PROPHYLAXIS; THROMBOEMBOLISM; RISK;
D O I
10.1007/s12325-010-0015-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Prophylaxis for venous thromboembolism (VTE) is underused following major surgery and frequently stopped at hospital discharge despite short stays and high VTE risk for several weeks postsurgery. We evaluated inpatient and postdischarge prophylaxis in patients who underwent major abdominal or orthopedic surgery. Patient records were assessed for anticoagulant use by cross-matching data from the Premier's Perspective (TM) discharge database with the i3/Ingenix LabRx outpatient and inpatient database from January 2005 to December 2007. Abdominal or orthopedic surgery patients at risk of VTE according to the 2004 American College of Chest Physicians guidelines and with no contraindications to anticoagulation were included. A total of 14,009 eligible surgical discharges were analyzed. Only 27.9% of the 10,698 abdominal surgery patients received anticoagulation in hospital. Most inpatients received unfractionated heparin (12.3% of the total abdominal surgery population) or enoxaparin (11.8%). Of the 3311 orthopedic surgery patients, 91.1% received in-hospital anticoagulation. Similar proportions of patients received enoxaparin (32.1%), warfarin (31.1%), or other agents (28.0%). Only 1.2% of abdominal surgery patients had an anticoagulant prescription filled 30 days postdischarge. Although orthopedic surgery outpatients had higher anticoagulation rates, only 54.4% had filled a prescription 30 days postdischarge with 31.1% receiving warfarin, 18.5% receiving enoxaparin, and 4.8% receiving other anticoagulants. The higher prophylaxis rate in orthopedic patients may reflect the high VTE risk in orthopedic surgery patients and increased awareness among orthopedic surgeons. This real-world study highlights the underuse of thromboprophylaxis in hospitalized surgical patients, especially following abdominal surgery. Furthermore, a considerable proportion of these patients do not receive postdischarge anticoagulation despite guideline recommendations. Further efforts are needed to improve anticoagulant use, particularly in the outpatient setting.
引用
收藏
页码:81 / 93
页数:13
相关论文
共 34 条
  • [1] Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)
    Amin, A.
    Spyropoulos, A. C.
    Dobesh, P.
    Shorr, A.
    Hussein, M.
    Mozaffari, E.
    Benner, J. S.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2010, 29 (03) : 326 - 339
  • [2] Amin Alpesh, 2008, Clin Adv Hematol Oncol, V6, P910
  • [3] Preventing venous thromboembolism in US hospitals: Are surgical patients receiving appropriate prophylaxis?
    Amin, Alpesh N.
    Stemkowski, Stephen
    Lin, Jay
    Yang, Guiping
    [J]. THROMBOSIS AND HAEMOSTASIS, 2008, 99 (04) : 796 - 797
  • [4] Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001 - Findings from the hip and knee registry
    Anderson, FA
    Hirsh, J
    White, K
    Fitzgerald, RH
    [J]. CHEST, 2003, 124 (06) : 349S - 356S
  • [5] Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism
    Anderson, Frederick A., Jr.
    Zayaruzny, Maxim
    Helt, John A.
    Fidan, Dogan
    Cohen, Alexander T.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (09) : 777 - 782
  • [6] [Anonymous], 2008, SURG GEN CALL ACT PR
  • [7] Pharmacology and management of the vitamin K antagonists
    Ansell, Jack
    Hirsh, Jack
    Hylek, Elaine
    Jacobson, Alan
    Crowther, Mark
    Palareti, Gualtiero
    [J]. CHEST, 2008, 133 (06) : 160S - 198S
  • [8] Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
    Bergqvist, D
    Benoni, G
    Bjorgell, O
    Fredin, H
    Hedlundh, U
    Nicolas, S
    Nilsson, P
    Nylander, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (10) : 696 - 700
  • [9] Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.
    Bergqvist, D
    Agnelli, G
    Cohen, AT
    Eldor, A
    Nilsson, PE
    Le Moigne-Amrani, A
    Dietrich-Neto, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13) : 975 - 980
  • [10] Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
    Cohen, Alexander T.
    Tapson, Victor F.
    Bergmann, Jean-Francois
    Goldhaber, Samuel Z.
    Kakkar, Ajay K.
    Deslandes, Bruno
    Huang, Wei
    Zayaruzny, Maksim
    Emery, Leigh
    Anderson, Frederick A., Jr.
    [J]. LANCET, 2008, 371 (9610) : 387 - 394